Changes in numerous clinical parameters have been shown to be prognostic for development of severe disease in human cases of COVID-19, including NLR, PT, aPTT, BUN, CRE, and BUN:CRE ratio [41–47]. This evidence concerns the gene F2 and COVID-19.